Trial sponsors searched for patients with your profile and these trials match. You decide whether to share your record. Compensation is set by the sponsor. Your specific Part 2 consent is required for any trial that touches substance-use or behavioral-health records.
Why this is different: Most trial match services match you and walk away. Moonlitic pays you when you enroll and runs every match through your active consent. You can withdraw at any time. Your data, your terms.
3
Trials matching your history
$2,200
If you accept all
1
Already accepted
5d
Soonest deadline
New matches — needs your decision
HER2-positive breast cancer · adjuvant therapy phase III
TRIAL-MA42-91 · MD Anderson Cancer Center · IRB 2026-MA42 · NCT05887421
$1,500
Total compensation
✓ IRB approved · expires 2027-12-31✓ Sponsor verified (CLINICAL_TRIAL company type)Houston, TX (in-person)~80 hours over 12 months
Capacity42 of 200 enrolled
Enrollment closes2026-09-30 (149 days)
ProtocolIRB-MA42-2026
Sponsor contactEnabled if you accept
Why we matched you
Dx: C50.911 (right breast malignancy)Age 52 ∈ range [40, 75]Gender: femaleNo prior trastuzumabState: TX
Continuous glucose monitor — adherence & outcomes study
TRIAL-CGM21-14 · Stanford School of Medicine · IRB 2026-STAN-7714 · NCT06014332
$400
Total compensation
✓ IRB approved · expires 2027-06-30✓ Academic Research (no commercial gain)Remote (decentralized)~16 hours over 6 months
Capacity187 of 500 enrolled
Enrollment closes2026-05-09 (5 days)
ProtocolIRB-STAN-CGM21
Sponsor contactEnabled if you accept
Why we matched you
Dx: E11.9 (Type 2 diabetes)Active CGM device on fileHbA1c last 90 days availableGeographic: any state
Behavioral-health adherence study (Part 2 protected)
TRIAL-BH04-22 · UNC School of Medicine · IRB 2026-UNC-4422
$300
Total compensation
✓ IRB approved · expires 2027-09-30⚠42 CFR Part 2 — extra written consent requiredRemote~24 hours over 9 months
Capacity8 of 60 enrolled
Enrollment closes2026-12-15
ProtocolIRB-UNC-BH04
RedisclosureProhibited (§2.32)
Why we matched you (you initiated this discovery)
Initiated by you on 2026-05-04Eligibility verified via your recordsSponsor never sees identifiers until you accept
In progress — you've accepted
Cardiac rehabilitation outcomes — phase IV observational